245 related articles for article (PubMed ID: 24391925)
1. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.
Alshalalfa M; Bader GD; Bismar TA; Alhajj R
PLoS One; 2013; 8(12):e84261. PubMed ID: 24391925
[TBL] [Abstract][Full Text] [Related]
2. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study.
Alshalalfa M; Bader GD; Goldenberg A; Morris Q; Alhajj R
BMC Syst Biol; 2012 Aug; 6():112. PubMed ID: 22929553
[TBL] [Abstract][Full Text] [Related]
3. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
PLoS One; 2012; 7(6):e40130. PubMed ID: 22768240
[TBL] [Abstract][Full Text] [Related]
4. miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.
Lewis H; Lance R; Troyer D; Beydoun H; Hadley M; Orians J; Benzine T; Madric K; Semmes OJ; Drake R; Esquela-Kerscher A
Cell Cycle; 2014; 13(2):227-39. PubMed ID: 24200968
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Wilk G; Braun R
Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
[TBL] [Abstract][Full Text] [Related]
6. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
7. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
[TBL] [Abstract][Full Text] [Related]
9. Widespread deregulation of microRNA expression in human prostate cancer.
Ozen M; Creighton CJ; Ozdemir M; Ittmann M
Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
[TBL] [Abstract][Full Text] [Related]
11. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
12. microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes.
Budd WT; Weaver DE; Anderson J; Zehner ZE
Chem Biodivers; 2012 May; 9(5):857-67. PubMed ID: 22589088
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
14. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
15. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
[TBL] [Abstract][Full Text] [Related]
16. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
18. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
Sun R; Fu X; Li Y; Xie Y; Mao Y
BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
[TBL] [Abstract][Full Text] [Related]
19. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures.
Alshalalfa M; Alhajj R
BMC Bioinformatics; 2013; 14 Suppl 12(Suppl 12):S1. PubMed ID: 24267745
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
